SLCTR_2019_021
Comparing the efficacy of Delta-Tocotrienol and resveratrol mixture vs placebo on reducing the cardiometabolic risk and associated biochemical markers in patients with Metabolic Syndrome – A Randomized Controlled Trial
Effects of Delta-tocotrienol and Resveratrol Supplementation on Cardiometabolic Risk Factors, Biochemical Markers and microRNAs in Patients with Metabolic Syndrome
AFIP / National University of Medical Sciences·Phase 2·Sri Lanka Clinical Trials Registry
Study focus
- Disease/Condition
- Metabolic Syndrome
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- AFIP / National University of Medical Sciences
- Location
- Pakistan
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Metabolic disordersMetabolic disorder, unspecifiedOther metabolic disordersOther specified metabolic disordersNutritional and metabolic disorders in diseases classified elsewhere
Data source
- Registry
- Sri Lanka Clinical Trials Registry
- Trial ID
- SLCTR_2019_021
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for SLCTR_2019_021 through Pure Global AI's free database. This Phase 2 trial is sponsored by AFIP / National University of Medical Sciences and is currently status unknown. The study focuses on Metabolic Syndrome.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.